Market Newsdesk

April 2, 2025 6:17 am

m-FINANCE Launches AI-Driven Commentary for mF4 Trading Platform

PR Newswire

HONG KONG
, April 2, 2025 /PRNewswire/ — m-FINANCE Limited (“m-FINANCE”), a wholly owned subsidiary of mF International Limited (the “Company” or “mF International”) (Nasdaq: MFI) and a provider of forex and bullion trading solutions in Asia, today announced the launch of “AI-Commentary”, an advanced analytical suite integrated into its mF4 Trading Platform. The solution combines m-FINANCE’s institutional expertise with DeepSeek AI’s (“DeepSeek”) large language models (“LLMs”), by which m-FINANCE expects to enable brokers to deliver actionable insights while improving operational efficiency.

The system aggregates real-time market data, including forex rates, bullion prices, and macroeconomic indicators, analyzing patterns across multiple timeframes and asset classes. By leveraging DeepSeek’s models, fine-tuned with financial datasets, AI-Commentary is designed to translate complex data into clear, easily readable insights that meet industry standards. m-FINANCE believes for brokers, the result is an innovative, scalable solution that provides new ways to engage with clients.

The Company expects that AI-Commentary will support brokers by bolstering operational efficiency and client retention, and by automating analytical tasks, it may reduce manual workloads, allowing teams to focus on strategic client interactions. For end-clients, it is anticipated that AI-Commentary will identify emerging opportunities and risks, delivering timely insights directly within the mF4 Platform interface with embedded TradingView charts and smart indicators. AI-Commentary comes in “Basic” and “Advanced” tiers across multiple languages while maintaining robust security and giving brokers full editorial control over regulatory compliance.

Building on this foundation, m-FINANCE is developing an AI Agent project to analyze traders’ risk appetites and trading styles, recommend optimal signals, and eventually automate trade execution. This and other advancements reflect m-FINANCE’s dedication to driving innovation for its global trading clients.

Mr. Chi Weng (Dick) Tam, the Executive Director and Chief Executive Officer of m-FINANCE, commented, “We are confident that our AI-Commentary feature will transform how brokers provide value to clients. By automating complex analysis while maintaining institutional-grade quality, we expect to help our partners boost client engagement and operational efficiency, allowing them to prioritize what matters most in their own client interactions. This launch represents our first significant step in integrating AI technology into our ecosystem, laying the foundation for upcoming projects, including our AI Agent, which we anticipate will further enhance the trading experience. We believe these developments will reinforce our two-decade commitment to innovation in forex and bullion trading solutions.”

About mF International Limited

mF International Limited is a British Virgin Islands holding company with three operating subsidiaries in Hong Kong. The Company’s principal Hong Kong subsidiary, m-FINANCE, is a Hong Kong-based experienced financial trading solution provider principally engaged in the development and provision of financial trading solutions via internet or platform as software as a service, or SaaS. m-FINANCE has approximately 20 years of experience providing real-time mission critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications and financial information for brokers and institutional clients in the region. With clients located over mainland China, Hong Kong and Southeast Asia, m-FINANCE provides customers with the mF4 Trading Platform, Trader Pro, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform “Broker+” Solution, Social Trading Apps and other value-added services. For more information, please visit the Company’s website: https://ir.m-finance.com/.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “views,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar words. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission.

For investor and media inquiries, please contact:

mF International Limited
Investor Relations Department
Email: [email protected]

ICR, LLC

Robin Yang

Email: [email protected]
Phone: (646) 308-1475

View original content:https://www.prnewswire.com/news-releases/m-finance-launches-ai-driven-commentary-for-mf4-trading-platform-302417902.html

SOURCE mF International Limited

April 2, 2025 6:16 am

The Number of Days You Need To Work To Afford a Monthly Mortgage Payment in Each State

PR Newswire

Highest number of days: Hawaii (17 days), California (15 days), Massachusetts (15 days) and Montana (15 days).
Lowest number of days: Kansas (7 days), Missouri (7 days), Indiana (7 days), Illinois (7 days), West Virginia (7 days), Michigan (7 days), and Ohio (6 days)

AUSTIN, Texas
, April 2, 2025 /PRNewswire/ — The median national home price in the U.S. is $412,000 and for Americans looking to buy a home, the magic number of days required to work per month to afford the mortgage payment is 10, according to Realtor.com^® data. But, for residents in some states, the number of workdays required can go up to 17 days, a whole week more.

“The number of workdays required to afford a home today stems from a couple factors. First, home prices have risen faster than incomes, widening the gap between earnings and housing costs. Second, elevated mortgage rates have increased borrowing costs, further stretching monthly budgets,” said Charlie Lankston, Executive Editor, Realtor.com^®. “As a result, prospective buyers must allocate more of their income, and consequently, more work days each month, to afford mortgage payments.”

More than half a month’s worth of work
Fittingly named the Paradise of the Pacific, it doesn’t come as a surprise that Hawaii is a sought after place to live. But, with that also comes the crown of the highest median home list price in the nation at $796,947. Homeowners purchasing a home at this price point will need to work 17 days each month just to cover the payment of $5,222, including tax and insurance, on average.

The in-demand state of California faces a similar trend, with homeowners having to work an average of 15 days of the month to cover a payment of $4,773, including tax and insurance. And, likely driven by an influx of people moving into the state and popular cities like Bozeman becoming more expensive, the average homeowner in Montana — where the median home list price is $613,275 — would also have to work 15 days of the month.

One week, or less
Meanwhile, the midwest and southeastern U.S. seaboard face a different reality. West Virginia and Ohio have the lowest median home list price, at $247,000 and $259,450, and residents need to work about seven and six days a month, respectively, to afford their mortgage payments. Other states that only require a week of work on average include Kansas, Missouri, Indiana, Illinois, West Virginia, and Michigan.

To read more about the number of days required to work to afford a mortgage payment visit Realtor.com.

Work Days Required Per Month To Afford a Mortgage Payment by State
State	Median Home List Price	Average Work Days Required to Afford the Mortgage Payment
Alabama	$321,720	9
Alaska	$422,500	9
Arizona	$488,500	12
Arkansas	$289,950	8
California	$728,500	15
Colorado	$559,475	12
Connecticut	$499,450	11
Delaware	$479,495	12
District of Columbia	$589,950	9
Florida	$435,000	11
Georgia	$380,000	9
Hawaii	$796,947	17
Idaho	$566,950	14
Illinois	$289,950	7
Indiana	$279,450	7
Iowa	$279,950	8
Kansas	$280,298	7
Kentucky	$299,000	8
Louisiana	$275,000	8
Maine	$449,450	11
Maryland	$408,323	9
Massachusetts	$749,950	15
Michigan	$265,350	7
Minnesota	$380,948	8
Mississippi	$289,900	9
Missouri	$289,000	7
Montana	$613,375	15
Nebraska	$346,925	9
Nevada	$485,598	13
New Hampshire	$574,950	13
New Jersey	$544,950	12
New Mexico	$389,700	11
New York	$659,974	14
North Carolina	$399,450	10
North Dakota	$363,322	9
Ohio	$259,450	6
Oklahoma	$294,995	8
Oregon	$550,000	12
Pennsylvania	$296,750	8
Rhode Island	$524,950	12
South Carolina	$352,450	9
South Dakota	$372,500	10
Tennessee	$419,965	11
Texas	$355,000	8
Utah	$586,200	14
Vermont	$497,500	12
Virginia	$422,325	10
Washington	$607,075	12
West Virginia	$247,000	7
Wisconsin	$379,450	9
Wyoming	$459,725	12

Methodology
To assess housing affordability, this analysis calculates the number of workdays needed to cover a median monthly mortgage payment in each state. The estimates are based on median home list prices as of February 2025 and assume a 30-year fixed mortgage at a 6.65% interest rate. Property taxes and insurance costs are factored in using a 1.7% annual rate, and calculations assume a 20% down payment. Wage data is from the Bureau of Labor Statistics’ January 2025 release, which tracks average hourly earnings across states.

About Realtor.com
^®Realtor.com^® pioneered online real estate and has been at the forefront for over 25 years, connecting buyers, sellers, and renters with trusted insights, professional guidance and powerful tools to help them find their perfect home. Recognized as the No. 1 site trusted by real estate professionals, Realtor.com^® is a valued partner, delivering consumer connections and a robust suite of marketing tools to support business growth. Realtor.com^® is operated by News Corp [Nasdaq: NWS, NWSA] [ASX: NWS, NWSLV] subsidiary Move, Inc.

Media Contact: Asees Singh, [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-number-of-days-you-need-to-work-to-afford-a-monthly-mortgage-payment-in-each-state-302417380.html

SOURCE Realtor.com

April 2, 2025 6:14 am

May River Capital Establishes a New Flow Control Platform, Tusk Industrial

PR Newswire

CHICAGO
, April 2, 2025 /PRNewswire/ — May River Capital (“May River“), a Chicago-based private equity firm focused on lower middle market industrial growth companies, announced today its acquisition of the Global Pump Solutions business of CECO Environmental Corp. (Nasdaq: CECO), including the highly respected Dean, Fybroc, and Sethco pump brands. Going forward, these three brands will be collectively organized under the parent company, Tusk Industrial, a newly formed portfolio company of May River. Tusk Industrial specializes in tough, high-performance pumping and fluid handling solutions engineered to excel in rugged environments.

Tusk Industrial designs, manufactures, and services metallic, fiberglass, and thermoplastic pumps for usage within a diverse range of high-temperature, corrosive, and caustic industrial environments, including chemical processing applications. Under the leadership of President & GM, Ming Cheung, the company has grown to over 100 employees serving over 1,500 customers globally across two locations in Telford, Pennsylvania and Indianapolis, Indiana. Cheung and the broader Tusk Industrial management team will continue to lead the organization under new ownership.

“Partnering with May River marks an exciting milestone for our company,” said Cheung. He went on to comment that, “this partnership unlocks incredible opportunities to supercharge our growth, expand our capabilities, and deliver even greater value to our customers. It’s an exciting time for our employees, customers, and partners as we take Tusk Industrial to new heights.”

Pat St. John, Managing Director of May River, stated, “Tusk Industrial is a standout business with significant growth potential, and we’re excited to partner with management to drive its continued success. With our deep expertise in building businesses within the flow control sector, we are committed to investing in new products, expanding into new markets, and pursuing strategic acquisitions – all with the goal of strengthening Tusk Industrial’s foundation and, most importantly, delivering greater value to its customer base.”

Paul Hastings and TD Securities served as legal and financial counsel to May River while Koley Jessen and EC M&A served as legal and financial counsel to CECO Environmental Corp.

About Tusk Industrial
Tusk Industrial specializes in tough, high-performance pumping and fluid handling solutions engineered to excel in rugged environments – ensuring reliability where failure isn’t an option. Tusk Industrial designs, manufactures, and services metallic, fiberglass, and thermoplastic pumps for usage within a diverse range of high-temperature, corrosive, and caustic industrial environments, including chemical processing applications. For more information, please visit www.tuskind.com.

About May River Capital
May River Capital is a Chicago-based private equity firm focused on partnering with lower middle-market industrial growth businesses. The firm invests in high-performing companies in advanced manufacturing, engineered products and instrumentation, specialized industrial services, and value-added industrial distribution services. For more information, please visit www.mayrivercapital.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/may-river-capital-establishes-a-new-flow-control-platform-tusk-industrial-302417693.html

SOURCE May River Capital, LLC

April 2, 2025 6:12 am

Cisco’s 2025 Data Privacy Benchmark Study: Privacy landscape grows increasingly complex in the age of AI

PR Newswire

News Summary

The Cisco 2025 Data Privacy Benchmark Study reveals increasing trust in global providers to protect and secure data
86% of respondents support privacy legislation, recognizing its positive impact on business operations
While 96% confirm that privacy investments provide returns exceeding costs, organizations anticipate resources and spending will likely shift to AI in the coming year
AI familiarity is rising, with 63% being very familiar with Generative AI, but concern for unintended risks continue

SAN JOSE, Calif.
, April 2, 2025 /PRNewswire/ — Cisco (NASDAQ: CSCO) today unveiled its 2025 Data Privacy Benchmark Study, offering a comprehensive analysis of privacy trends and their profound implications for businesses worldwide. As data privacy remains critical to establishing business value and trust, the study uncovers a complex landscape where the demand for local data storage intersects with reliance on global providers’ expertise. Conducted across 12 countries with insights from 2,600 privacy and security professionals, the eighth edition Data Privacy Benchmark Study demonstrates the growing importance of establishing solid data privacy foundations to unleash the full potential of AI.

“Privacy and proper data governance are foundational to Responsible AI,” said Dev Stahlkopf, Cisco Chief Legal Officer. “For organizations working toward AI readiness, privacy investments establish essential groundwork, helping to accelerate effective AI governance.”

Concerns around safety and security drive data residency decisions

Despite increased operational costs of data localization, 90% of organizations see local storage as inherently safer, while 91% (up five percentage points year-over-year) trust global providers for better data protection. These dual data points reveal today’s complex privacy landscape: global providers are valued for their capabilities, but local storage is perceived as safer.

“The drive for data localization reflects rising interest in data sovereignty,” said Harvey Jang, Cisco’s Chief Privacy Officer. “Yet, a thriving, global digital economy relies on trusted cross-border data flows. Interoperable frameworks such as the Global Cross-Border Privacy Rules Forum will play a vital role in enabling growth while effectively addressing crucial privacy and security concerns.”

Building Trust Through Compliance: The Business Advantage of Privacy Laws

Privacy legislation remains a cornerstone of customer trust, with 86% of respondents noting a positive impact on their organizations, up from 80% last year. Despite the costs associated with compliance, a resounding 96% of organizations report that the returns significantly outweigh the investments.

This sentiment is echoed by the increasing consumer awareness and confidence in privacy laws mentioned in the 2024 Cisco Consumer Privacy Survey, where most global consumers (53%) said they are aware of their country’s privacy laws. Among those aware, 81% feel confident in their ability to protect their data, compared to just 44% of those unaware of such laws.

Privacy: The Cornerstone of Responsible AI in the GenAI Era

As familiarity with AI increases—63% of respondents are now very familiar with Generative AI (GenAI)—concerns remain steady year-over-year. Despite many organizations reporting significant business gains from GenAI, data privacy is still a major risk. Notably, 64% of respondents worry about inadvertently sharing sensitive information publicly or with competitors, yet nearly half admit to inputting personal employee or non-public data into GenAI tools. This gap highlights the need for tools like Cisco’s AI Defense which safeguard against the misuse of AI tools and data leakage.

In turn, there is an increased focus on investing in AI governance processes among respondents, where an overwhelming 99% of respondents anticipate reallocating resources from privacy budgets to AI initiatives in the future. The 2024 Cisco AI Readiness Index emphasizes this trend, revealing that IT budget allocations are anticipated to nearly double in the coming year as companies work to safely deploy AI technology. Cisco will continue to monitor this shift in future research, recognizing that both privacy and AI governance play a combined role in establishing safe and reliable AI systems.

AI and Privacy: Catalysts for Business Growth and Customer Loyalty

Cisco’s annual study highlights the need for organizations to balance local data storage, global expertise, and privacy in an AI-driven world. It emphasizes the need to view data governance as an essential strategic investment for aligning AI strategies with privacy, ensuring sustainable growth and consumer trust.

Additional Resources:

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has securely connected the world. With its industry leading AI-powered solutions and services, Cisco enables its customers, partners and communities to unlock innovation, enhance productivity and strengthen digital resilience. With purpose at its core, Cisco remains committed to creating a more connected and inclusive future for all. Discover more on The Newsroom and follow us on X at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at http://www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word ‘partner’ does not imply a partnership relationship between Cisco and any other company.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ciscos-2025-data-privacy-benchmark-study-privacy-landscape-grows-increasingly-complex-in-the-age-of-ai-302417333.html

SOURCE Cisco Systems, Inc.

April 2, 2025 6:11 am

NEW Fit Exchange by DXL + Military & First Responders Discount Offers New Savings for All Big + Tall Men

PR Newswire

CANTON, Mass.
, April 2, 2025 /PRNewswire/ — Destination XL Group, Inc. (Nasdaq: DXLG), the leading integrated-commerce retailer specializing in Big + Tall men’s clothing and shoes, is proud to announce two new cost-saving initiatives designed to bring a heightened level of exceptional value and recognition to its guests – our newly announced Fit Exchange by DXL program and a program supporting those who serve us all.

In late February, Fit Exchange by DXL launched, offering customers an easy way to donate clothing and refresh their wardrobe, while giving back. Customers can bring in clothing that no longer fits them to any of the 250+ DXL Big + Tall or Casual Male XL locations and receive 20% off their in-store purchase of new, better-fitting styles. All donated items will be distributed locally, supporting those in need within the community.

“At DXL, we believe every man deserves clothing that fits perfectly, so he can look good and feel good.” said Harvey Kanter, President and Chief Executive Officer of DXL.
“That said, we are dedicated to continuing to find ways to provide value at a time when customers are really looking for it.”

The next exciting announcement is the introduction of the DXL Heroes Discount. This exclusive 15% discount is available to active military personnel, veterans, first responders, healthcare workers, and teachers – both in-store at DXL Big + Tall and Casual Male XL locations, as well as online at DXL.com.

As a token of appreciation for their dedication, this program helps these everyday heroes refresh their wardrobes with great-looking styles that fit comfortably.
By teaming up with GOVX, the largest online marketplace dedicated to serving those who serve, DXL will be added to a list of respected retailers offering such discounts.

“These new initiatives are about more than just savings – they’re about empowering our guests to step into the styles they love and to wear what they want,” Kanter went on to say. “Whether it’s through our Fit Exchange by DXL program or exclusive discount honoring heroes, we’re here to ensure every man can find the perfect fit and embrace his unique style.”

About Destination XL Group

Destination XL Group, Inc. is the leading retailer of Men’s Big + Tall apparel that provides the Big + Tall man the freedom to choose his own style. Subsidiaries of Destination XL Group, Inc. operate DXL Big + Tall retail and outlet stores and Casual Male XL retail and outlet stores throughout the United States, an e-commerce website, DXL.com, and mobile app, which offer a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for Big + Tall men. The Company is headquartered in Canton, Massachusetts, and its common stock is listed on the Nasdaq Global Market under the symbol “DXLG.” For more information, please visit the Company’s investor relations website:

https://investor.dxl.com

.

Related Links

http://www.DXL.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-fit-exchange-by-dxl–military–first-responders-discount-offers-new-savings-for-all-big–tall-men-302417324.html

SOURCE Destination XL Group, Inc.

April 2, 2025 6:10 am

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein (a-syn) antibody levels on average over 20-fold higher than placebo after 4 immunizations
Repeated immunizations amplify the anti-a-syn antibody response, supporting boostability and the potential to further increase antibody titers
ACI-7104.056 is well tolerated with no safety issues reported to date

Lausanne, Switzerland, April 2, 2025 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced additional interim safety and positive immunogenicity data from the Phase 2 VacSYn clinical trial evaluating ACI-7104.056, its wholly owned anti-alpha-synuclein (a-syn) active immunotherapy candidate, for the treatment of patients with early Parkinson’s disease (PD).

Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “We continue to be encouraged by the data emerging from the Phase 2 VacSYn trial of ACI-7104.056 active immunotherapy in early Parkinson’s disease. These additional interim safety and immunogenicity data after 6 months of treatment underscore the good safety profile and reinforce the best-in-class characteristics of ACI-7104.056 for the treatment of Parkinson’s disease. We look forward to sharing further updates later in 2025.”

VacSYn is an adaptive, placebo-controlled, and biomarker-based Phase 2 study in patients with early PD, consisting of two parts with a seamless transition. Part 1 includes initial analyses from over 30 patients randomized to receive ACI-7104.056 or placebo at a ratio of 3:1. To date, in the blinded, pooled active and placebo groups, no serious adverse event considered related to the study drug has been reported. The most common adverse events are mild and transient injection site reactions and headaches, generally of mild severity.

Interim results show positive antibody responses were effectively induced against the target antigen at week 6 after 2 immunizations and were further boosted by each additional immunization. Treatment with ACI-7104.056 induced an increase in anti-a-syn antibodies on average over 20-fold higher than the placebo background level after four immunizations.

Based on further interim results to be reported later in 2025 including pharmacodynamic and biomarker data, AC Immune may decide to initiate Part 2 of VacSYn with up to 150 patients. Further exploratory endpoints for patients in Part 2 will include the evaluation of the progression of motor and non-motor symptoms of the disease, as well as digital, imaging, and fluid biomarkers. The aim is to establish early proof-of-concept and identification of disease-specific biomarkers for rapid transition into a pivotal study.

About ACI-7104.056

ACI-7104.056 is an optimized formulation of its clinically validated anti-a-syn predecessor active immunotherapy which generated a target-specific antibody response against pathological oligomeric a-syn to inhibit spreading and downstream neurodegeneration in early Parkinson’s disease. The accumulation of alpha-synuclein protein aggregates has been shown to cause inflammatory stress in cells and contribute to the degeneration of neurons in the brain. It has been known to play a key role in the development of neurodegenerative diseases such as Parkinson’s Disease. Previous clinical studies showed the predecessor candidate produced a strong and boostable antibody response with evidence of target engagement and a signal of clinical efficacy.

About AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features a range of therapeutic and diagnostic programs, including candidates in Phase 2 and Phase 3 development. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive funding to advance its proprietary programs and >$4.5 billion in potential milestone payments plus royalties.

SupraAntigen® is a registered trademark of AC Immune SA in the following territories: AU, EU, CH, GB, JP, RU, SG and USA. Morphomer® is a registered trademark of AC Immune SA in CN, CH, GB, JP, KR, NO and RU.

The information on our website and any other websites referenced herein is expressly not incorporated by reference into, and does not constitute a part of, this press release.

For further information, please contact:

Head of Investor Relations & Corporate Communications

Gary Waanders, Ph.D., MBA
AC Immune
Phone: +41 21 345 91 91
Email: [email protected]

International Media

Chris Maggos
Cohesion Bureau
Phone: +41 79 367 6254
Email: [email protected]

Forward looking statements

This press release contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical fact and may include statements that address future operating, financial or business performance or AC Immune’s strategies or expectations. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “outlook” or “continue,” and other comparable terminology. Forward-looking statements are based on management’s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include those described under the captions “Item 3. Key Information – Risk Factors” and “Item 5. Operating and Financial Review and Prospects” in AC Immune’s Annual Report on Form 20-F and other filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and AC Immune does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law. All forward-looking statements are qualified in their entirety by this cautionary statement.

Attachment

20250401_ACIU_VacSYn Interim_final

April 2, 2025 6:09 am

The Ensign Group Adds Two Operations in California

SAN JUAN CAPISTRANO, Calif., April 02, 2025 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign^TM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of Alamitos West Health and Rehabilitation, a 142-bed skilled nursing facility, and Katella Senior Living Community, a 68-unit senior living facility. Both facilities are located in Los Alamitos, California and subject to a long-term, triple net lease with a third-party landlord. This acquisition was effective as of April 1, 2025.

“We are thrilled to add these two operations in one of our most mature markets,” said Barry Port, Ensign’s Chief Executive Officer. “These operations join an already strong operating cluster, and we can’t wait to build on what’s already been created here,” he added.

Adam Willits, President of Flagstone Healthcare South LLC, Ensign’s California-based subsidiary, commented, “These two facilities have such an incredible team of caregivers and we look forward to working together to serve this healthcare community with both post-acute and senior living services. As we strive to follow proven operating principles, we believe these operations can reach new heights in clinical excellence.”

In a separate transaction on the same day, Ensign announced that it acquired the real estate and operations of Pacific Haven Subacute and Healthcare Center, a 99-bed skilled nursing facility located in Garden Grove, California. The real estate assets were purchased by Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company and operations were leased to an Ensign-affiliated operator, subject to a long-term lease.

Standard Bearer also acquired the real estate to Emilie Court Assisted Living, a 60-unit senior living facility located in Spokane, Washington; and Mother Joseph Care Center, a 152-bed skilled nursing facility located in Olympia, Washington. Each of these facilities will be operated by a third-party operator and are subject to long-term triple-net leases.

All of these acquisitions are effective as of April 1, 2025 and bring Ensign’s growing portfolio to 343 healthcare operations, which includes 44 senior living operations, across 17 states. Ensign subsidiaries, including Standard Bearer, own 143 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, senior living and other healthcare related businesses throughout the United States.

About Ensign

^TM

The Ensign Group, Inc.’s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 343 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.

Contact Information

The Ensign Group, Inc., (949) 487-9500, [email protected]

SOURCE: The Ensign Group, Inc.

April 2, 2025 6:08 am

The Ensign Group Expands in California

SAN JUAN CAPISTRANO, Calif., April 02, 2025 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of Pacific Haven Subacute and Healthcare Center, a 99-bed skilled nursing facility located in Garden Grove, California. The real estate was acquired by a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company, and will be operated by an Ensign-affiliated tenant. The acquisition is effective as of April 1, 2025.

“We are truly honored to have been entrusted to continue the legacy we inherit in this operation, which has been owned and operated by the prior owner for decades,” said Barry Port, Ensign’s Chief Executive Officer. “We are also excited to add to our existing footprint in one of our most mature markets while simultaneously increasing Standard Bearer’s footprint,” he added.

Adam Willits President of Flagstone Healthcare South LLC, Ensign’s California-based subsidiary, added, “Pacific Haven has such an incredible clinical reputation within the community, that we couldn’t be more excited to partner with the amazing team of caregivers there to continue that tradition of excellence they have earned over a long period of time.”

In a separate transaction on the same day, Ensign announced that it acquired the operations of Alamitos West Health and Rehabilitation, a 142-bed skilled nursing facility, and Katella Senior Living Community, a 68-unit senior living facility. Both facilities are located in Los Alamitos, California and subject to a long-term, triple-net lease with a third-party landlord.

These acquisitions are effective as of April 1, 2025, and bring Ensign’s growing portfolio to 343 healthcare operations, which includes 44 senior living operations, across 17 states. Ensign subsidiaries, including Standard Bearer, own 143 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, senior living and other healthcare related businesses throughout the United States.

About Ensign™

Contact Information

The Ensign Group, Inc., (949) 487-9500, [email protected]

SOURCE: The Ensign Group, Inc.

April 2, 2025 6:07 am

YXT.com Rebrands as Radnova and Launches AI-Enabled Enterprise Productivity Solutions

SUZHOU, China, April 02, 2025 (GLOBE NEWSWIRE) — YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced that it has successfully completed a strategic rebranding initiative, adopting the “Radnova” name for its potential international operations. YXT.com operates its business in China through Jiangsu Radnova Intelligence Technology Co., Ltd. (formerly Jiangsu Yunxuetang Network Technology Co., Ltd.). The “Radnova” trademark will be used for the Company’s future international operations, symbolizing its transition from a China-focused e-learning company to a global AI-enabled enterprise productivity solutions provider.

This strategic rebranding comes amid rapid transformation in the enterprise AI market. The global AI agent market is projected to grow significantly in the future, with many professionals already using AI agents in work environments. The Company announced this strategic move at a launch event in Beijing, positioning Radnova to expand beyond digital learning into the broader enterprise productivity space.

The Company’s rebranding is built on proven internal AI implementation since 2018, when it first began applying AI technologies to its operations. Currently, AI technology has been integrated into 90% of the Company’s core positions, yielding measurable improvements. The intelligent customer service system now achieves 100% user coverage with a 94.8% self-resolution rate. These practical applications directly inform Radnova’s enterprise solutions.

“In the process of enterprise intelligent transformation, humans and AI will form a double-helix symbiotic relationship,” said Mr. Xiaoyan Lu, Director, Founder, and Chairman of the Board of YXT.com. “Building collaborative productivity between people and AI has become an unstoppable trend of our era. Authoritative data shows that the rapid adoption of AI work assistants and intelligent agent-based applications has become the definitive path for enterprise intelligent transformation. Our transformation journey that began within our own operations now extends to helping enterprises worldwide build this ‘human + AI’ collaborative productivity model.”

Building on this expertise, Radnova is launching four AI-powered solution categories: Intelligent Talent Management, Agent Services, Knowledge Base systems, and Work Assistants. The Intelligent Talent Management solution has demonstrated a 67% improvement in talent management efficiency, while the Agent Services platform accelerates intelligent transformation by enabling organizations to build and deploy AI agents efficiently, and has helped reduce customer issue resolution time by 75% through its intelligent customer service application. The Enterprise Knowledge Base systems transform proprietary knowledge into unique productivity assets, creating distinctive competitive advantages for organizations. Work Assistants, particularly for sales teams, have shortened sales cycle time and improved coaching efficiency. These integrated solutions reflect the Company’s vision of human-AI collaboration and position Radnova as a pioneer in enterprise intelligence transformation, ready to serve organizations worldwide.

As part of its global expansion, the Company has established a new entity in Singapore to serve as a headquarters for its overseas business to be conducted in the future. This strategic location will enable YXT.com to better serve and expand into international markets.

About YXT.com

YXT.com (NASDAQ: YXT) is a technology company focusing on enterprise productivity solutions. With a mission to “Empower people and organization development through technology,” The Company strives to become the supreme provider in building and boosting enterprise productivity by combining over a decade of experience in tech-enabled talent learning and development and with AI-augmented task copilots and unleashing the power of knowledge and synergy. Since its inception, YXT.com has supported and received recognition from numerous Global and China Fortune 500 companies.

YXT.com operates its business in China through “Jiangsu Radnova Intelligence Technology Co., Ltd.,” formerly known as “Jiangsu Yunxuetang Network Technology Co., Ltd.”. YXT.com has established an entity in Singapore to serve as a headquarter for its overseas business to be conducted in the future, with the “Radnova” trademark to serve international markets.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to”, or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

Contact

Robin Yang
ICR, LLC
[email protected]
+1 (646) 405-4883

April 2, 2025 6:06 am

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services

MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica

BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan product is now available in Santa Monica at Medical Imaging Center of Southern California (MICSC). Until now, MICSC has provided Nociscan exclusively at their Beverly Hills location.

“We are pleased to expand access to Nociscan in our Santa Monica location,” said Bradley Jabour, MD, founder of MICSC. “MICSC has a proud heritage of adoption of new and novel solutions that add value to our patients and referring physician customers. Nociscan has been an integral part of our Beverly Hills service offering and by adding it in Santa Monica we are expanding our services while replicating the benefits to patients and physicians currently provided in Beverly Hills. Physicians treating low back pain are constantly striving for more and better information when diagnosing and treating patients. Nociscan is helping physicians who treat low back pain and we are pleased to offer Nociscan at both our Los Angeles locations.”

In November 2024, Dr. Jabour was highlighted in an article about Nociscan in the Radiological Society of North America edition of MAGNETOM Flash, a peer-to-peer magazine published by Siemens Healthineers. The article features two physician-user perspectives on Nociscan, one from a spine surgeon and the other from Dr. Jabour’s point of view as a radiologist and imaging center owner.

Chronic low back pain (cLBP) is a global healthcare problem with approximately 266 million people worldwide suffering from degenerative spine disease and low back pain. Los Angeles is the most populous city in California, with an estimated population exceeding 3.8M people, and the second-most populous city in the United States, second only to New York City. Both Los Angeles and New York City are strategically important markets for Aclarion.

Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain.

To find a Nociscan center, view our site map here.

For more information on Nociscan, please email: [email protected]

All organizations cited and/or quotes from individuals not part of Aclarion have reviewed and approved the contents herein.

About Aclarion, Inc.

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company’s current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as “anticipates,” “believes” and “expects” or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contacts:

Kirin M. Smith
PCG Advisory, Inc.
[email protected]

Media Contacts:

Jennie Kim
SPRIG Consulting
[email protected]